ANI Pharmaceuticals, Inc.

Q4 2023 13F Holders

Symbol
ANIP
CUSIP
00182C103
Type
Equity
Class
COM
Num filings
187
Total reported value, excl. options
$752 M
Manager Report Date Value ($000) Shares Option Type